A.Catalyst Network

The home of patient-enabled innovation


Home / Partnering / A.Catalyst Network


Introducing A.Catalyst Network

A.Catalyst Network is an interconnected and dynamic global network of more than 20 AstraZeneca health innovation hubs, made up of physical locations and virtual partnerships, bringing together digital, R&D, and commercial resources to reimagine how we can improve patient outcomes.


Innovation in action: Our vision for the future of healthcare

A.Catalyst Network brings together diverse stakeholders across industry and geographical boundaries to address healthcare challenges by working together. Our aim is to deliver real impact for patients, society, and business. 

We believe that patient experiences and outcomes are our shared responsibility, and that innovation doesn’t happen in isolation.



Through A.Catalyst Network, we are co-creating challenge-based solutions with and for patients and working with partners to establish integrated and strong health systems that benefit the whole patient experience — from prevention and awareness, diagnosis and treatment, to post-treatment and wellness.



Our vision

Patients are at the centre of everything we do across A.Catalyst Network. You can find out more about our values and vision in our Video Manifesto.


Join our mission to shape the future of healthcare

Could you be our next partner? Do you have a proposal to submit for consideration by our A.Catalyst Network Hubs teams? If you have an ambition to improve outcomes for patients around the world, we want to know about it.


Our impact in numbers


20+

hub locations

200+

partnerships

100+

solutions in development

220+

start-ups mentored


10

solutions scaled after pilot


Explore our A.Catalyst Network hubs

Americas



Argentina
 

Learn more here

Brazil
 

US: Boston BioHub
 


US: Willmington Hub
 

Learn more here

US: San Francisco Hub
 

Learn more here

Europe



France
 

Israel: BioBeyond
 

Poland
 

Learn more here

Russia
 

Sweden: BioVentureHub
 

Sweden: Health Works
 


United Kingdom 
 


Asia



China iCampus Hub

Taiwan Hub

Hong Kong Hub

Learn more here

Gulf Cooperation Council (GCC)
 

Learn more here

Japan: i2.jp Innovation Infusion
 


Malaysia
 

Learn more here

Singapore
 

Learn more here

Oceania



Australia & New Zealand
 

Learn more here


Our partners include

Patients | Healthcare practitioners | Governments and policy makers | Academia | Tech and pharma industries | Ecosystem builders | Investors | Entrepreneurs

Anchor partners


Our focus areas


Artificial Intelligence (AI)

We are developing Artificial Intelligence (AI) solutions to support the screening, detection, diagnosis, staging and management of lung cancer, breast cancer and COPD, and to help healthcare professionals identify cardio-renal complications in type 2 diabetes patients. These solutions align with our Cardiovascular, Renal and Metabolism (CVRM), Oncology, and Respiratory & Immunology therapy areas, and aim to address unmet need in the prevention and awareness, diagnosis, treatment and post-treatment stages of the patient journey.


Digital apps 

We are developing digital app solutions to help healthcare professionals analyse chest x-rays, and provide patients with online consultations, e-prescriptions and support in managing conditions such as asthma, diabetes, heart failure, breast cancer and lung cancer. These solutions align with our Cardiovascular, Renal and Metabolism (CVRM), Oncology, and Respiratory & Immunology therapy areas, and aim to address unmet need in the prevention and awareness, diagnosis, treatment, post-treatment and wellness stages of the patient journey.


Co-incubation programmes 

We are developing co-incubation programmes to support biomedical tech start-ups engaged in the research and development of integrated oncology solutions, and offer coaching, co-working spaces, shared equipment, regulatory support, and financial subsidy. These programmes align with our Oncology therapy area and aim to address unmet need in the prevention and awareness, diagnosis, treatment, post-treatment and wellness stages of the patient journey.


Our 2021 priorities


Veeva ID: Z2-2008
Date of preparation: September 2021